Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protocol For A Multicentre, Double Blind, Parallel Group Pilot Study To Compare Celecoxib Long Term Vs Celecoxib Short Term Therapy In Treatment And Prevention Of New Flare In Patients With Osteoarthritis Of The Knee

NCT00137410 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00137410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00137410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protocol For A Multicentre, Double Blind, Parallel Group Pilot Study To Compare Celecoxib Long Term Vs Celecoxib Short Term Therapy In Treatment And Prevention Of New Flare In Patients With Osteoarthritis Of The Knee
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2002
Completion date
March 31, 2006
Enrollment
200
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis,knee